Tumor Markers in Cancer diagnosis and Monitoring
A substance produced by a tumor or by the host in response to the tumor's presence & can be detected in blood, body fluids or tissue of the host.
Pathology Simplified
Tumor associated antigen (TAA)
You can suggest me topics by commenting below or reach out at microbialconcepts@gmail.com Enjoy learning !!!! Do share these videos with your friends.
microbial concepts
How to dissociate tumor tissue
Watch how you can quickly and easily dissociate tumor tissue from mouse using the gentleMACS™ Dissociator. Speed up your workflow for dissociating tumor ...
Miltenyi Biotec
Immunotherapy: Boosting the immune system to fight cancer
The concept of 'teaching' the immune system to recognize and destroy cancer cells is over a century old, but the development of immunotherapeutic strategies ...
nature video
immunology lectures Immune Response to Tumors Tumor Antigens & Antitumor Immunity
Bashar Qudah
Cancer Metabolism: From molecules to medicine
It takes years to discover and develop a new medication. But what does this long-term, complicated process actually involve? In this seminar, Harvard Medical ...
Harvard Medical School
Unleashing the T-cell army | Cancer immunotherapy at Roche
Cancer immunotherapy helps us enhance our immune systems so that they're able to fight cancer, enabling our bodies' T-cell armies to attack the tumour ...
Roche
Simultaneous multi-analyte profiling of rare antigen specific T cells with 3D Flow™ Analysis
Karen Anderson, MD, PhD, Professor, Arizona State University Dr. Karen Anderson M.D., Ph.D., is a Professor at Arizona State University. She received her M.D. ...
LabRoots
Stem Cell Antigens as Therapeutic Targets In Prostate Cancer
Stem Cell Antigens as Therapeutic Targets In Prostate Cancer by Robert Reiter, M.D., Geffen School of Medicine at UCLA.
UBC Urology Rounds
COVID-19: Enrichment and analysis of rare antigen- and virus-specific T cells
Presented By: Marcello Stein, PhD Speaker Biography: Marcello Stein Ph.D. received his doctoral degree in immunology from the University of ...
LabRoots
How Does the Immune System Identify Self vs Nonself?
Learn how the body identifies self (the body's own normal cells) from nonself (foreign or abnormal cells) through both innate and adaptive immunity. See more ...
Dig Deeper Into Immuno-Oncology Research
Immuno-oncology and immunotherapy introduction
Discover the basics of immuno-oncology and the latest trends in immunotherapy.
Cisbio
How do monoclonal antibodies work? Rituximab, infliximab, adalimumab and others
This video contains a detailed and simplified explanation of how monoclonal antibodies such as rituximab, infliximab, adalimumab, ranibizumab and ...
Zero To Finals
CAR T-cell Therapy for Pediatric Cancer | Satiro de Oliveira, MD | UCLAMDChat
Join UCLA pediatric oncologist Satiro De Oliveira, MD, for a discussion about CAR T-cell therapy for pediatric patients, including indications, plan of care, side ...
UCLA Health
Monoclonal antibodies in medicine
Explore some of the key milestones in the development and engineering of monoclonal antibodies and the role they play in medicine. Learn more about drug ...
Roche
Aiming the Immune System at Brain Cancer, with David Reardon
In this webinar designed for patients and caregivers, David A. Reardon, M.D., discussed current immunotherapy treatment options for patients with brain cancer, ...
Cancer Research Institute
Role of Regulatory T Cells in Tolerance: Implication in Human Diseases
Air date: Wednesday, March 24, 2010, 3:00:00 PM Time displayed is Eastern Time, Washington DC Local Category: Wednesday Afternoon Lectures Description: ...
NIH VideoCast
Pathophysiology of Cancer
Dr Greg
Glioblastoma: From Diagnosis to Treatment
Glioblastoma, also known as GBM, represent 14.9% of all primary brain tumors, and 55.4% of all gliomas. GBM has the highest number of cases of all malignant ...
American Brain Tumor Association
How Do Tumors Use PD-1 to Cause T-Cell Exhaustion?
Learn how overexpression of PD-1 receptors on T cells may lead to T-cell exhaustion. See more healthcare professional resources at ...
Dig Deeper Into Immuno-Oncology Research
AbLearning™ - Episode 3: Chimeric Antigen Receptor T Cell Therapy
AbLearning™ Educational Program hosted by Abnova. Chimeric antigen receptor (CAR) T cell therapy has stirred a hot debate in clinic since the first CAR T cell ...
Abnova
Personalized Cancer Treatment with Immunotherapy
In some sense, every person's cancer is unique. However, for several reasons, patients are often treated in a one-size-fits-all manner, usually based on where ...
Cancer Research Institute
Dr Maitra speaks on "Why is Pancreatic Cancer so Hard to Treat & What Can We Do About It?"
Dr. Anirban Maitra on MD Anderson Cancer Center speaks on "Why is Pancreatic Cancer so Hard to Treat & What Can We Do About It?" at the 13th Annual ...
HirshbergFoundation
Bladder Cancer, Causes, Signs and Symptoms, Diagnosis and Treatment.
Bladder cancer is any of several types of cancer arising from the tissues of the urinary bladder. It is a disease in which cells grow abnormally and have the ...
Medical Centric
CAR T-Cell Therapy: How Does It Work?
CAR T-cell therapy, like all forms of cancer immunotherapy, seeks to sharpen and strengthen the immune system's inherent cancer-fighting powers. It involves ...
Dana-Farber Cancer Institute
Cancer Antigen Mnemonic
Here's a fun way to remember the testable cancer antigens! For more fun visit Baronerocks.com.
baronerocks
Oncogenetics - Mechanism of Cancer (tumor suppressor genes and oncogenes)
What markers do I use? FaberCastellPITTartistpens1,5 FaberCastellPITTartistpensF FaberCastellPermanentmarkers FaberCastellPITTartistpensbrush.
Armando Hasudungan
Tumor Neo-Antigens by Professor Bruce Robinson
Professor Bruce Robinson from the School of Medicine and Pharmacology QEII Medical Centre Unit, The University of Western Australia presents his talk in the ...
IIIDVideos
Using Impedance-Based Approaches for Measuring Antigen-Specific Cytotoxic T cell Activity
Immunotherapy, where the immune system is harnessed to treat and/or prevent disease, holds great promise in the fight against cancer. One noteworthy facet of ...
ACEA Biosciences - A part of Agilent
Sting Operation: Using Scorpion Venom to Target Brain Tumors | City of Hope
City of Hope scientists have developed and tested the first chimeric antigen receptor (CAR) T cell using chlorotoxin, a component of scorpion venom, to direct T ...
City of Hope
Cancer | Cells | MCAT | Khan Academy
An introduction to what cancer is and how it is the by-product of broken DNA replication. Created by Sal Khan. Watch the next lesson: ...
Khan Academy
Pancreatic Cancer and Immunotherapy with Dr. Elizabeth M. Jaffee
There are limited effective treatments for most patients with advanced pancreatic cancer. It is the world's most lethal cancer and the fourth-leading cause of ...
Cancer Research Institute
Stephen Schoenberger: How Does Cancer Avoid the Immune System?
Immunotherapy, an entirely new approach the employs the power of one's own immune system, has shown to be effective in treating cancers that were fatal just ...
UC San Diego Health
Immunotherapy for NSCLC - Video abstract 57550
Video abstract of review paper "New modalities of cancer treatment for NSCLC: focus on immunotherapy" published in the open access journal Cancer ...
Dove Medical Press
Imaging cancer stem cell antigen CD133 with a novel zirconium-89 labelled antibody
Kevin Wyszatko - AO Mondays.
Ontario Institute for Cancer Research - OICR
Immunotherapy - PD-1 and Beyond - Melanoma Education Symposium, Patrick Ott MD PhD
Dr. Patrick Ott, Assistant Orofessor of Medicine at Harvard Medical School, Dana Farber Cancer Center speaks on the future of immunotherapy and clinical trials ...
ImmunoOncology
Timm Jessen: Generating antigen-specific immune tolerance using peptide-loaded nanoparticles
Full title: Timm Jessen: Generating antigen-specific immune tolerance through liver targeted peptide-loaded nanoparticles Mastering Immunity Europe 2017 ...
ProImmune thinkpeptides
CD4 Chimeric Antigen Receptors to Re-direct CD4 T cells to Target HIV Infection
Presented By: James L Riley, PhD, Andrea Love, PhD Speaker Biography: James L Riley, PhD: James L. Riley, PhD, is an Professor of Microbiology at the ...
LabRoots
Improving MHC-associated peptide sequencing approaches for tumor antigen identification
Harnessing the immune system to treat cancer is a relatively new therapeutic avenue, and therapies that target neoantigens, either directly or indirectly, have ...
Cayman Chemical
Immunotherapy in lung cancer: Panacea vs. reality?
In this presentation from the 22nd Annual Perspectives in Thoracic Oncology, Dr. Joshua Bauml discusses the current state of immunotherapy in the treatment of ...
ImedexCME
How to biohack your cells to fight cancer - Greg Foot
Check out the science of biohacking, where biologists go into a patient's genetic code and reprogram their immune system to recognize and fight cancer cells.
TED-Ed
ESGCT e-School: Directing the immune response to specific tumor antigens using modified oncolytic vi
Speaker: Vincenzo Cerullo, University of Helsinki Chair: Hildegard Büning, Hannover Medical School.
European Society for Gene and Cell Therapy
